ES2079743T3 - Tableta para chupar o masticar. - Google Patents
Tableta para chupar o masticar.Info
- Publication number
- ES2079743T3 ES2079743T3 ES92110680T ES92110680T ES2079743T3 ES 2079743 T3 ES2079743 T3 ES 2079743T3 ES 92110680 T ES92110680 T ES 92110680T ES 92110680 T ES92110680 T ES 92110680T ES 2079743 T3 ES2079743 T3 ES 2079743T3
- Authority
- ES
- Spain
- Prior art keywords
- alkaline
- weight
- acid
- edible
- tablet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000001055 chewing effect Effects 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 3
- 239000004135 Bone phosphate Substances 0.000 abstract 2
- 150000007524 organic acids Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 1
- 239000007910 chewable tablet Substances 0.000 abstract 1
- 229940068682 chewable tablet Drugs 0.000 abstract 1
- 239000002270 dispersing agent Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 235000003599 food sweetener Nutrition 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000003765 sweetening agent Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 229920002554 vinyl polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/22—Gas releasing
- A61K2800/222—Effervescent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Confectionery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
LA TABLETA DESLEIBLE O MASTICABLE CONTIENE COMO BASE AL MENOS 30, PERO PREFERENTEMENTE 50 HASTA 70% EN PESO, DE UNA SAL ALCALINA Y/O ALCALINOTERREA DE AL MENOS UN ACIDO COMESTIBLE ORGANICO; AL MENOS 10, PREFERENTEMENTE 20 HASTA 40% EN PESO, DE UNA MEZCLA DE AL MENOS UN ACIDO NO REACTIVO, COMESTIBLE, ORGANICO CON AL MENOS UN CARBONATO Y/O BICARBONATO NO REACTIVO ALCALINO Y/O ALCALINOTERREO ASI COMO, DADO EL CASO, UNA SUSTANCIA ACTIVA FARMACEUTICA Y/O LAS SUSTANCIAS AUXILIARES PARA TABLETAS USUALES COMO AROMATIZANTES Y EDULCORANTES, SUSTANCIAS AUXILIARES DE DESINTEGRACION, HIDROCOLOIDES, ETC. CONTIENE ESENCIALMENTE LA SAL BIBASICA ALCALINA Y/O ALCALINOTERREA DE UN ACIDO TRIBASICO, COMESTIBLE, ORGANICO, ESPECIALMENTE DEL ACIDO CITRICO, ASI COMO PREFERENTEMENTE UN ACIDO COMESTIBLE, ORGANICO, ESPECIALMENTE SOLO REACTIVO PARCIALMENTE CON LA SAL ALCALINA Y/O ALCALINOTERREA, ESPECIALMENTE ACIDO MALICO, QUE ES MAS FUERTE QUE EL ACIDO TRIBASICO ASI COMO, DADO EL CASO, REFERIDO AL PESO TOTAL DE LA TABLETA, DE 1 HASTA 10, PREFERENTEMENTE 3 HASTA 7% EN PESO, DE AL MENOS UN AGENTE DISPERSANTE, ESPECIALMENTE UN 3% EN PESO DE ALMIDON Y POLIVINILPOLIPIRROLIDONA RETICULADA TRANSVERSAL.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH194391 | 1991-07-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2079743T3 true ES2079743T3 (es) | 1996-01-16 |
Family
ID=4222226
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92110680T Expired - Lifetime ES2079743T3 (es) | 1991-07-01 | 1992-06-25 | Tableta para chupar o masticar. |
Country Status (8)
Country | Link |
---|---|
US (1) | US5312626A (es) |
EP (1) | EP0525388B1 (es) |
JP (1) | JP3372053B2 (es) |
AT (1) | ATE128027T1 (es) |
CA (1) | CA2072513C (es) |
DE (1) | DE59203732D1 (es) |
DK (1) | DK0525388T3 (es) |
ES (1) | ES2079743T3 (es) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2700669B1 (fr) * | 1993-01-22 | 1995-04-14 | Tassoni Jean Pierre | Composition effervescente pour la préparation de boissons gazeuses. |
DE59407351D1 (de) * | 1993-09-09 | 1999-01-07 | Gerhard Gergely | Brausegranulat und verfahren zu seiner herstellung |
DE4333190C2 (de) * | 1993-09-29 | 1996-05-30 | Korsatko Werner Univ Prof Dr E | Zerbeißtablette mit verzögerter Wirkstoff-Freisetzung |
ES2134457T3 (es) * | 1994-04-22 | 1999-10-01 | Dibona Holding Ag | Caramelo con efecto neutralizante del sarro. |
US6352713B1 (en) * | 1999-12-01 | 2002-03-05 | Drugtech Corporation | Nutritional composition |
US6488956B1 (en) * | 1994-06-20 | 2002-12-03 | Drugtech Corporation | Multi-vitamin and mineral supplements for women |
DE19502789A1 (de) * | 1995-01-28 | 1996-08-01 | Dirk Krischenowski | Arzneimittel |
FR2732217B1 (fr) * | 1995-03-29 | 1997-06-06 | Hesnard Xavier | Forme d'administration solide a usage oral |
CN1192137A (zh) * | 1995-07-31 | 1998-09-02 | 格哈特·格戈里 | 有泡腾效应的咀嚼片剂 |
ATE429212T1 (de) * | 1995-12-26 | 2009-05-15 | Cns Inc | Verabreichungssystem für inulindiätfasern |
US6974595B1 (en) * | 1996-05-17 | 2005-12-13 | Proethic Pharmaceuticals, Inc. | Pharmaceutical compositions based on Diclofenae |
DE19649730A1 (de) * | 1996-08-08 | 1998-02-12 | Eu Rho Pharma Gmbh | Mittel zur Stärkung des menschlichen Organismus |
US6344222B1 (en) | 1998-09-03 | 2002-02-05 | Jsr Llc | Medicated chewing gum delivery system for nicotine |
US6358060B2 (en) | 1998-09-03 | 2002-03-19 | Jsr Llc | Two-stage transmucosal medicine delivery system for symptom relief |
US6261600B1 (en) * | 1999-04-30 | 2001-07-17 | Drugtech Corporation | Folic acid supplement |
DE19962251A1 (de) * | 1999-12-22 | 2001-09-06 | Hermes Fabrik Pharm Praeparate | Lutschtablette |
WO2001089476A1 (en) * | 2000-05-19 | 2001-11-29 | Npd Llc | Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements |
GB0012261D0 (en) * | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel process |
JP2002087965A (ja) * | 2000-09-14 | 2002-03-27 | Lion Corp | 口中崩壊性アスピリン含有錠剤 |
FR2822700B1 (fr) * | 2001-04-03 | 2007-04-06 | Frederic Dana | Nouveau produit d'hygiene dentaire sous forme de nutricament unidose gelifiant d'action prolongee et compositions nouvelles adaptees en comprime ou gel semisolide |
CN1980948B (zh) * | 2002-11-27 | 2011-08-10 | Dmi生物科学公司 | 治疗由增强磷酸化介导的疾病和病况 |
CN1886126A (zh) * | 2003-09-25 | 2006-12-27 | Dmi生物科学公司 | 利用n-酰基-l-天冬氨酸的方法和产品 |
JP4917255B2 (ja) * | 2003-10-16 | 2012-04-18 | 第一三共ヘルスケア株式会社 | サリチル酸類含有経口組成物 |
US8216610B2 (en) | 2004-05-28 | 2012-07-10 | Imaginot Pty Ltd. | Oral paracetamol formulations |
WO2005115345A1 (en) * | 2004-05-28 | 2005-12-08 | Imaginot Pty Ltd | Oral therapeutic compound delivery system |
US8202546B2 (en) * | 2005-08-04 | 2012-06-19 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for use under physiologically stressful conditions |
US7998500B2 (en) * | 2005-08-04 | 2011-08-16 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for women |
US8263137B2 (en) * | 2005-08-04 | 2012-09-11 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for women |
US7901710B2 (en) * | 2005-08-04 | 2011-03-08 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for use under physiologically stressful conditions |
CA2629904C (en) * | 2005-11-28 | 2018-07-10 | Imaginot Pty Ltd. | Oral therapeutic compound delivery system |
DE102006029233A1 (de) * | 2006-06-26 | 2007-12-27 | Liedtke, Rainer K., Dr. | Formulierungen zur Verbesserung der Verträglichkeit nichtsteroidaler Antiphlogistika |
US8642016B2 (en) | 2006-07-21 | 2014-02-04 | Jsrnti, Llc | Medicinal delivery system, and related methods |
US20100009012A1 (en) * | 2008-07-11 | 2010-01-14 | Zukkoor N David | Chewable pharyngeal inflammation symptom relief composition |
EP2441436A1 (de) * | 2010-10-13 | 2012-04-18 | Fresenius Medical Care Deutschland GmbH | Phosphatbinderformulierung zur einfachen Einnahme |
US20140371174A1 (en) | 2013-06-12 | 2014-12-18 | The Procter & Gamble Company | Effervescent Dosage Form |
CA2876062C (en) | 2012-06-12 | 2017-09-12 | The Procter & Gamble Company | Effervescent dosage form |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2984543A (en) * | 1957-03-19 | 1961-05-16 | Pierre F Smith | Stabilization of effervescent carbonate powders |
FR1484202A (fr) * | 1965-07-05 | 1967-06-09 | Andreu Sa Dr | Procédé de préparation d'un composé acide pour compositions effervescentes |
US3887700A (en) * | 1969-11-28 | 1975-06-03 | Aspro Nicholas Ltd | Analgesic formulations |
US4664915A (en) * | 1981-07-01 | 1987-05-12 | Bristol-Myers Company | Compressed and formed alkaline component suitable for use in buffered aspirin product |
DE3440288A1 (de) * | 1984-11-05 | 1986-05-07 | Gergely, Gerhard, Dr.-Ing., Wien | Pharmazeutische zubereitung mit einem gehalt an mindestens einer schleimhautreizenden substanz oder dergleichen, insbesondere profen, sowie verfahren zu ihrer herstellung |
US4650669A (en) * | 1985-07-30 | 1987-03-17 | Miles Laboratories, Inc. | Method to make effervescent calcium tablets and calcium tablets produced thereby |
GB8525348D0 (en) * | 1985-10-15 | 1985-11-20 | Nicholas Kiwi Pacific Pty Ltd | Effervescent tablets |
FR2593065B1 (fr) * | 1986-01-22 | 1988-09-09 | Smith Kline French Lab | Couples effervescents, compositions effervescentes d'antagonistes h2 de l'histamine les contenant et leur preparation. |
DE3627475A1 (de) * | 1986-06-26 | 1988-01-14 | Gergely Gerhard | Verfahren zum herstellen eines brausegranulates, danach hergestelltes brausegranulat sowie dessen verwendung |
US4867989A (en) * | 1986-09-09 | 1989-09-19 | Warner-Lambert Company | Chewing gum mineral supplement |
US5096714A (en) * | 1988-06-28 | 1992-03-17 | Hauser-Kuhrts, Inc. | Prolonged release drug tablet formulations |
US5064656A (en) * | 1989-11-14 | 1991-11-12 | Dr. Gergely & Co. | Uncoated pharmaceutical reaction tablet |
-
1992
- 1992-06-25 EP EP92110680A patent/EP0525388B1/de not_active Expired - Lifetime
- 1992-06-25 DE DE59203732T patent/DE59203732D1/de not_active Expired - Lifetime
- 1992-06-25 ES ES92110680T patent/ES2079743T3/es not_active Expired - Lifetime
- 1992-06-25 DK DK92110680.3T patent/DK0525388T3/da active
- 1992-06-25 AT AT92110680T patent/ATE128027T1/de active
- 1992-06-26 CA CA002072513A patent/CA2072513C/en not_active Expired - Fee Related
- 1992-07-01 JP JP17407292A patent/JP3372053B2/ja not_active Expired - Fee Related
- 1992-07-01 US US07/907,507 patent/US5312626A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP3372053B2 (ja) | 2003-01-27 |
CA2072513A1 (en) | 1993-01-02 |
US5312626A (en) | 1994-05-17 |
JPH05186334A (ja) | 1993-07-27 |
ATE128027T1 (de) | 1995-10-15 |
EP0525388A1 (de) | 1993-02-03 |
CA2072513C (en) | 2002-03-26 |
DK0525388T3 (da) | 1996-02-05 |
DE59203732D1 (de) | 1995-10-26 |
EP0525388B1 (de) | 1995-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2079743T3 (es) | Tableta para chupar o masticar. | |
AR003014A1 (es) | Tableta masticable con efecto efervescente | |
US5635209A (en) | Stabilized composition of levothyroxine sodium medication and method for its production | |
EA200500891A1 (ru) | Фармацевтические композиции, содержащие щелочные или соответственно кислые лекарственные соединения, поверхностно-активное вещество и физиологически приемлемую водорастворимую кислоту или соответственно основание | |
KR950007841A (ko) | 트라마돌 염을 함유하는 서방성 약물 제제 | |
ES2034010T3 (es) | Formulacion para la administracion de farmacos por via oral y metodo para prepararla. | |
AR087210A2 (es) | Formulacion farmaceutica de la sal sodica del telmisartan | |
ES2051800T3 (es) | Tableta cubierta de dihidropiridina. | |
ES2058411T3 (es) | Sustancia fr 901228 y su preparacion. | |
ES2136157T3 (es) | Producto granular o comprimido que contiene un sistema efervescente y una sustancia farmaceutica activa, asi como un procedimiento para su preparacion. | |
MY117587A (en) | Acid-triggered release microcapsules | |
ES2086011T3 (es) | Chicle farmaceutico con acido acetilsalicilico. | |
PT1207756E (pt) | Utilizacao de espinosade ou de uma formulacao que compreende espinosade | |
CL2009001680A1 (es) | Composiciones agroquimicas que comprenden a)metconazol o una sal del mismo y b)un acido carboxilico alifatico de cadena lineal o ramificada, saturado o no saturado y donde la relacion molar de (b) respecto de (a) es superior a 1 | |
AR012480A1 (es) | Una unidad de dosis farmaceutica que comprende tibolona, un metodo para elaborarla y el uso de un producto de almidon como vehiculo en unidades dedosis farmaceuticas que comprenden tibolona | |
ES2530791T3 (es) | Formulación de ibandronato de altas dosis | |
MX9400800A (es) | Un complejo de estabilizacion neutro para ci-979 hci, un activador de la cognicion. | |
SV1998000119A (es) | Formulacion medicamentosa con liberacion controlada de sustancia activa. ref. lea 32671-sv | |
EA199900102A1 (ru) | Таблетка малеата тримебутина, покрытая оболочкой | |
ES2136139T3 (es) | Componente farmaceutico de accion ralentizada que contiene acido bilico como componente activo. | |
AR019899A1 (es) | Composicion farmaceutica y un procedimiento para prepararla. | |
TW350772B (en) | Tablets with improved bioavailability of the active material clodronic acid | |
AR023138A1 (es) | Composicion para gomas de mascar medicadas, proceso de fabricacion y tabletas obtenidas con dicho proceso | |
JPS6466105A (en) | Stabilized insecticidal composition | |
ATE117202T1 (de) | Vitamin enthaltende formulierungen und deren herstellung. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 525388 Country of ref document: ES |